Literature DB >> 26221273

Cordyceps sinensis preserves intestinal mucosal barrier and may be an adjunct therapy in endotoxin-induced sepsis rat model: a pilot study.

Guo-Sheng Gu1, Jian-An Ren1, Guan-Wei Li1, Yu-Jie Yuan2, Ning Li1, Jie-Shou Li1.   

Abstract

BACKGROUND: Cordyceps sinensis (C. sinensis), a traditional Chinese medicine, exhibits various pharmacological activities such as reparative, antioxidant, and apoptosis inhibitory effects. Intestinal barrier dysfunction plays a vital role in the progression of sepsis. We aimed to explore the effect of C. sinensis on the gut barrier and evaluate its efficacy in sepsis.
METHODS: A murine model of gut barrier dysfunction was created by intraperitoneal injection of endotoxin. C. sinensis or saline was administered orally after the induction of sepsis. Alterations of intestinal barrier were evaluated and compared in terms of epithelial cell apoptosis, proliferation index (PI), intercellular tight junction (TJ) and proliferating cell nuclear antigen (PCNA).
RESULTS: C. sinensis significantly decreased the percentage of apoptotic cells and promoted mucosal cells proliferation indicated by enhanced PI and PCNA expression in the intestinal mucosa compared to control group. The TJs between epithelial cells which were disrupted in septic rats were also restored by treatment of C. sinensis. In survival studies, C. sinensis was demonstrated to confer a protection against the lethal effect of sepsis.
CONCLUSION: These results suggest that C. sinensis has gut barrier-protection effect in endotoxin-induced sepsis by promoting the proliferation and inhibiting the apoptosis of intestinal mucosal cells, as well as restoring the TJs of intestinal mucosa. C. sinensis may have the potential to be a useful adjunct therapy for sepsis.

Entities:  

Keywords:  Cordyceps sinensis; gut barrier; intestinal barrier; sepsis

Year:  2015        PMID: 26221273      PMCID: PMC4509218     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

Review 1.  Intestinal barrier: an interface between health and disease.

Authors:  Ashkan Farhadi; Ali Banan; Jeremy Fields; Ali Keshavarzian
Journal:  J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 4.029

2.  [Comparison of some pharmacological effects between Cordyceps sinensis (Berk). Sacc. and Cephalosporium sinensis Chen sp. nov].

Authors:  Q Wang; Y Zhao
Journal:  Zhong Yao Tong Bao       Date:  1987-11

3.  Quality control of Cordyceps sinensis, a valued traditional Chinese medicine.

Authors:  S P Li; F Q Yang; Karl W K Tsim
Journal:  J Pharm Biomed Anal       Date:  2006-02-28       Impact factor: 3.935

4.  Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis.

Authors:  Jong-Ho Koh; Kwang-Won Yu; Hyung-Joo Suh; Yang-Moon Choi; Tae-Seok Ahn
Journal:  Biosci Biotechnol Biochem       Date:  2002-02       Impact factor: 2.043

5.  The fruiting body and its caterpillar host of Cordyceps sinensis show close resemblance in main constituents and anti-oxidation activity.

Authors:  S P Li; Z R Su; T T X Dong; K W K Tsim
Journal:  Phytomedicine       Date:  2002-05       Impact factor: 5.340

Review 6.  The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II.

Authors:  J S Zhu; G M Halpern; K Jones
Journal:  J Altern Complement Med       Date:  1998       Impact factor: 2.579

7.  Disruption of epithelial barrier by quorum-sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases.

Authors:  Sung Yong Eum; Dima Jaraki; Luc Bertrand; Ibolya E András; Michal Toborek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

8.  Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.

Authors:  R Gennari; J W Alexander; L Gianotti; T Eaves-Pyles; S Hartmann
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

9.  Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs.

Authors:  Jinghua Peng; Xuemei Li; Qin Feng; Liang Chen; Lili Xu; Yiyang Hu
Journal:  Exp Biol Med (Maywood)       Date:  2013-06

10.  Protective roles of Cordyceps on lung fibrosis in cellular and rat models.

Authors:  Mengli Chen; Florence W K Cheung; Ming Hung Chan; Pak Kwan Hui; Siu-Po Ip; Yick Hin Ling; Chun-Tao Che; Wing Keung Liu
Journal:  J Ethnopharmacol       Date:  2012-07-13       Impact factor: 4.360

View more
  3 in total

1.  The Function of Ophiocordyceps sinensis in Airway Epithelial Cell Senescence in a Rat COPD Model.

Authors:  Xiaohui Ma; Xingai Jiao; Jinxiang Wu; Jiping Zhao; Yurong Xu; Tian Liu; Jiawei Xu; Lei Yang; Liang Dong
Journal:  Can Respir J       Date:  2018-04-01       Impact factor: 2.409

2.  Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.

Authors:  Kaitao Yuan; Jinning Ye; Zhenguo Liu; Yufeng Ren; Weiling He; Jianbo Xu; Yulong He; Yujie Yuan
Journal:  J Exp Clin Cancer Res       Date:  2020-01-13

Review 3.  Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

Authors:  Xu-Hua Wang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Rui-Jia Fu; Lu Huang; Yu-Ping Tang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.